The proposed CY 2027 Medicare Physician Fee Schedule has sparked alarm among practitioners who fear the cumulative impact of reduced payments for treatment planning, medical physics, and essential management services. Industry leaders now face the challenge of quantifying how these cuts could destabilize cancer programs and limit patient access to specialized care nationwide.
Radiation Oncology Providers Urged to Challenge Proposed Medicare Cuts
With a September 14 deadline looming, Radiation Business Solutions is mobilizing oncology providers to confront the Centers for Medicare & Medicaid Services over proposed reimbursement shifts for 2027. The firm warns that while some treatment codes see gains, critical areas including proton therapy and stereotactic procedures face significant financial pressure.
Sally Eggleston, COO of Radiation Business Solutions, argues that the current proposals fail to account for the long-term viability of community-based cancer care. To assist in the pushback, the firm has released a suite of customizable advocacy tools and template letters designed to guide providers through the formal comment process. Stakeholders have until September 14 to submit their feedback to federal regulators, a window the firm hopes will be used to illustrate the tangible risks these payment reductions pose to local healthcare communities.
Comments (0)
No comments yet. Be the first!